Currently, no approved treatments of zebra and quagga mussels provide effective eradication strategies in open water. There are currently no biopesticides utilizing immunotoxin technology for the remediation of aquatic nuisance species. Engineered toxin body (ETB) and Immunotoxin technologies are well validated in human health applications and can be utilized for environmental application. Production of such biopesticides in commercial micro-algae production vectors offer a low cost, high yield solution. This approach lowers the risk of unintended harm to native ecologies, lowers production cost, and requires a lower effective dose than previously approved biopesticides.
